Grupo para la caracterización molecular de las neoplasias hematológicas
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (27)
2024
-
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096
-
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962
2023
-
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma
Journal of Thrombosis and Thrombolysis, Vol. 55, Núm. 3, pp. 464-473
-
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
Frontiers in Immunology, Vol. 14
2022
-
Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study
Clinical Infection in Practice, Vol. 13
-
Infusion of haploidentical NKG2D-CAR-TCD45RA- cells in two pediatric patients with advanced relapsed and refractory acute leukemia was safe but achieved no clinical benefits
Leukemia and Lymphoma
-
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Frontiers in Immunology, Vol. 13
2021
-
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 5, pp. 328-337.e1
2020
-
Tyk2 variants in b-acute lymphoblastic leukaemia
Genes, Vol. 11, Núm. 12, pp. 1-16
2019
-
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Haematologica, Vol. 104, Núm. 2, pp. 288-296
-
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
The Lancet Oncology, Vol. 20, Núm. 6, pp. e302-e312
-
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data
BMC Cancer, Vol. 19, Núm. 1
2018
-
How do we manufacture clinical-grade interleukin-15–stimulated natural killer cell products for cancer treatment?
Transfusion, Vol. 58, Núm. 6, pp. 1340-1347
-
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Haematologica
-
Serial tuberculin skin tests improve the detection of latent tuberculosis infection in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 12, Núm. 11, pp. 1270-1279
2017
-
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma
Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106
-
Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory Bowel disease
Journal of Crohn's and Colitis, Vol. 11, Núm. 7, pp. 792-800
-
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase
PLoS ONE, Vol. 12, Núm. 7
2014
-
Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation
Leukemia, Vol. 28, Núm. 6, pp. 1334-1340
2012
-
Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients
BMC Gastroenterology, Vol. 12